Evogene (EVGN) Set to Announce Earnings on Thursday

Evogene (NASDAQ:EVGN) is set to release its earnings data before the market opens on Thursday, November 21st. Investors interested in registering for the company’s conference call can do so using this link.

Evogene (NASDAQ:EVGN) last issued its earnings results on Thursday, August 22nd. The biotechnology company reported ($1.06) EPS for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.94). Evogene had a negative net margin of 210.26% and a negative return on equity of 72.33%. The firm had revenue of $0.91 million during the quarter.

Evogene Price Performance

Shares of EVGN stock opened at $1.73 on Wednesday. The firm has a market cap of $9.26 million, a P/E ratio of -0.44 and a beta of 1.43. Evogene has a fifty-two week low of $1.66 and a fifty-two week high of $10.40. The stock’s 50-day moving average is $2.47 and its two-hundred day moving average is $4.56.

Wall Street Analysts Forecast Growth

Several research firms have commented on EVGN. Lake Street Capital decreased their target price on shares of Evogene from $30.00 to $12.00 and set a “buy” rating for the company in a research report on Friday, August 23rd. StockNews.com started coverage on shares of Evogene in a report on Monday. They issued a “sell” rating for the company.

Evogene Company Profile

Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The company operates through three segments: Agriculture, Human Health, and Industrial Applications.